1 / 17

EURO-WABB An EU rare diseases registry for Wolfram syndrome, Alström syndrome and Bardet-Biedl syndrome

EURO-WABB An EU rare diseases registry for Wolfram syndrome, Alström syndrome and Bardet-Biedl syndrome . Prof. Timothy Barrett Euro-WABB Project Leader Ms. Amy Farmer Euro-WABB Project Manager. www.euro-wabb.org Euro-wabb@bch.nhs.uk. The Problem: Different combinations of symptoms.

karik
Download Presentation

EURO-WABB An EU rare diseases registry for Wolfram syndrome, Alström syndrome and Bardet-Biedl syndrome

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. EURO-WABBAn EU rare diseases registry for Wolfram syndrome, Alström syndrome and Bardet-Biedl syndrome • Prof. Timothy Barrett • Euro-WABB Project Leader • Ms. Amy Farmer • Euro-WABB Project Manager www.euro-wabb.org Euro-wabb@bch.nhs.uk

  2. The Problem:Different combinations of symptoms Isolated vision impairment Common diabetes Non-syndromic deafness Vision loss Diabetes Hearing loss • WARNING !!! • Failure to diagnose patterns • Too rare for doctors to learn • Little or no research • Inadequate patient information • Failure to treat properly • WARNING!!! Cardiomyopathy Obesity Common obesity Isolated cardiomyopathy Rare Disease Day 2012 - Rare but Strong Together

  3. Project OverviewInitiated by MdmNolwenJaffre Association syndrome de Wolfram • Funded by the European Union in the Framework of the Health Programme (contract ref: 2010-12-05) • 3 year project which began on 01/01/2011 • 9 Associate Partners across Europe • European Rare Diseases Registry collecting clinical and diagnostic data • Wolfram, Alström and Bardet-Biedl (WABB) syndromes and other syndromes such as Wolcott-Rallison and Thiamine-Responsive Megaloblastic Anaemia (TRMA) • Project activities divided into 6 work packages: coordination, dissemination, evaluation; genetics, clinical guidelines, and rare disease European Registry

  4. The WABB diseases Wolfram Childhood diabetes, optic atrophy, deafness, neuro-degeneration Alström Obesity, retinal dystrophy, deafness, often cardiomyopathy and diabetes Bardet-Biedl Obesity, retinal dystrophy, deafness, often diabetes, polydactyly, cystic kidneys Plus: Wolcott-Rollison syndrome Roger’s syndrome Other even rarer syndromes

  5. ObjectivesTo support efficient diagnosis, treatment, and research for WABB diseases in Europe • To identify barriers to doctors using an EU-wide registry • To agree data to collect on each rare disease • To develop and road test a web based registry • To identify and catalogue all mutations for each disease and genotype/phenotype correlations • To assess patient information /professional learning needs • To write information for patients/professionals Common datasets WHO classification Mutation Database Diagnostic network Information/Education E.g. AS-UK handbook

  6. Description of the project Clinical Partners: take consent from patients to input their data anonymously Patient partners: register themselves, see own data records, input quality of life data EU-WABB Registry 300 anonymised patient records: medical, genetic, investigations, quality of life. State of the art security Research Partners: Regulated access to data Platform for clinical trials No direct access to patients Outputs: Genetic testing network Natural history of WABB diseases Evidence based patient information Learning materials for health professionals

  7. Value added of collaborating across Europe • Value added: • Network of genetic testing laboratories • Critical mass to enable high quality research • Patient numbers for clinical trials • Quicker progress to new treatments for these diseases • Sharing of best practice • Health professionals and Patient support groups working as partners Wolfram syndrome UK

  8. Collaborative Links & Expressions of Interest

  9. Genetics Identify and catalogue mutations (published & unpublished) in the RDS genes • Leiden Open source Variation • Database (LOVD) software • Current variants 1017, of which • 358 are unique variants.

  10. Supporting Equal Access to Genetic Testing W W West Midlands Regional Genetics Lab, UK Antwerp University Hospital, BELGIUM WABB Diagnostic Laboratories A W CHU Nice, FRANCE O O Royal Devon and Exeter NHS Trust, UK W Radboud University, Nijmegen Medical Centre, Netherlands A B B North East Thames Regional Molecular Genetics Laboratory, UK W Medical University of Lodz, Poland A A University of Padua, ITALY A Universidad de Vigo, SPAIN

  11. EURO-WABB Registry https://registry.euro-wabb.org • Web-based data collection undertaken by local clinician with input from patient or parent/guardian

  12. Ethics: extract from UK form

  13. Data Collection Form • 44 Data fields in the Core dataset • 370 data fields in the Extended dataset • Capturing clinical and molecular genetic features • Onset of Symptoms • Phenotyping information • Standardised using ICD-10 and ESPE Classification coding systems

  14. Selecting ‘Yes’ for a particular symptom prompts for further detail (ICD-10 code) and age of onset of symptoms

  15. Local Participants

  16. Current Recruitment • Ethical approvals in place in Poland, Italy, Spain, Estonia and the UK • Ethics applications underway in Germany, Denmark and France • Collaborative links established with further sites keen to take part • Total Registry Participants: 81

  17. Acknowledgements: EURORDIS Mme. NolwenJaffre Associate Partners www.euro-wabb.org Thank you

More Related